A Randomized Controlled Trial of Tacrolimus Versus Cyclosporine After Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 26, Issue 10, 2007, Pages 1012-1018

  Hachem, Ramsey R ^a   Yusen, Roger D ^a   Chakinala, Murali M ^a   Meyers, Bryan F ^a   Lynch, John P ^a   Aloush, Aviva A ^a   Patterson, G Alexander ^a   Trulock, Elbert P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; BRONCHITIS; CANCER; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG FIBROSIS; LUNG TRANSPLANTATION; LYMPHOCYTIC BRONCHITIS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; RECURRENT INFECTION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INFECTION;

ADULT; AZATHIOPRINE; BRONCHIOLITIS OBLITERANS; BRONCHITIS; CYCLOSPORINE; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; TACROLIMUS;

EID: 34848820264     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.07.027     Document Type: Article

References (26)

1. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplant report--2006. J Heart Lung Transplant 25 (2006) 880-892
2. Valentine V.G., Robbins R.C., Berry G.J., et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 15 (1996) 371-383
3. Husain A.N., Siddiqui M.T., Holmes E.W., et al. Analysis f risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 159 (1999) 829-833
4. Sharples L.D., McNeil K., Stewart S., and Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 21 (2002) 271-281
5. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001:an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
6. Hachem R.R., Khalifah A.P., Chakinala M.M., et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 80 (2005) 1406-1413
7. Kobashigawa J.A., Patel J., Furukawa H., et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant 25 (2006) 434-439
8. Pollock-BarZiv S.M., Dipchand A.I., McCrindle B.W., Nalli N., and West L.J. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-months follow-up. J Heart Lung Transplant 24 (2005) 190-194
9. Keenan R.J., Konishi H., Kawai A., et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 60 (1995) 580-585
10. McCurry K.R., Zaldonis D.B., Keenan R.J., et al. Long term follow-up of a prospective randomized trial of tacrolimus versus cyclosporine in human lung transplantation [abstract 87]. Am J Transplant 2 suppl 3 (2002) 159
11. Zuckermann A., Reichenspurner H., Birsan T., et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg 125 (2003) 891-900
12. Hachem R.R., Chakinala M.M., Yusen R.D., et al. The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med 169 (2004) 468-472
13. Lama V.N., Murray S., Mumford J.A., et al. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients. Am J Respir Crit Care Med 172 (2005) 379-383
14. King-Biggs M.B., Dunitz J.M., Park S.J., Kay Savik S., and Hertz M.I. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation 75 (2003) 1437-1443
15. Groetzner J., Kur F., Spelsberg F., et al. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant 23 (2004) 632-638
16. Hachem R.R., Chakinala M.M., Yusen R.D., et al. A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation. J Heart Lung Transplant 24 (2005) 1320-1326
17. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. Lung Rejection Study Group. J Heart Lung Transplant 15 (1996) 1-15
18. Freemantle N., Calvert M., Wood J., Eastaugh J., and Griffin C. Composite outcomes in randomized trials. Greater precision but with greater uncertainty?. JAMA 289 (2003) 2554-2559
19. Yousem S.A. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol 17 (1993) 491-496
20. Glanville A.R., Aboyoun C.L., Havryck A., Rainer S., and Malouf M.A. Severity of lymphocytic bronchiolitis predicts long term outcome after lung transplantation [abstract 133]. J Heart Lung Transplant 26 suppl (2007) S107
21. Burton C.M., Andersen C.B., Jensen A.S., et al. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab. J Heart Lung Transplant 25 (2006) 638-647
22. Snell G.I., Valentine V.G., Vitulo P., et al. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. Am J Transplant 6 (2006) 169-177
23. Stallone G., Infante B., Schena A., et al. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 16 (2005) 3755-3762
24. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
25. Cantarovich M., Besner J.G., Barkun J.S., Elstein E., and Loertscher R. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transplant 12 (1998) 243-249
26. Morton J.M., Aboyoun C.L., Malouf M.A., Plit M.L., and Glanville A.R. Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation. J Heart Lung Transplant 23 (2004) 1035-1039